# Estimation of the ED95 of Intrathecal Hyperbaric Prilocaine 2% With Sufentanyl for Scheduled Cesarean Delivery

> **NCT03036384** · PHASE2 · COMPLETED · sponsor: **Centre Hospitalier Universitaire Saint Pierre** · enrollment: 40 (actual)

## Conditions studied

- Pregnant Women

## Interventions

- **DRUG:** HB Prilocaine 2% (varying dose)
- **DRUG:** HB Prilocaine 2%
- **DRUG:** Sufentanil
- **DRUG:** Morphine

## Key facts

- **NCT ID:** NCT03036384
- **Lead sponsor:** Centre Hospitalier Universitaire Saint Pierre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2020-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03036384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03036384, "Estimation of the ED95 of Intrathecal Hyperbaric Prilocaine 2% With Sufentanyl for Scheduled Cesarean Delivery". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03036384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*